5 Best One Dollar Stocks to Buy Today

In this article, we discuss the 5 best one dollar stocks to buy today. If you want to read our detailed analysis of these stocks, go directly to the 11 Best One Dollar Stocks to Buy Today

5. Avenue Therapeutics, Inc. (NASDAQ:ATXI)

Number of Hedge Fund Holders: 4    

Real-Time Share Price as of December 14: $1.00    

Avenue Therapeutics, Inc. (NASDAQ:ATXI) is a specialty pharma firm that focuses on the development of products for intensive care. One of the leading product candidates for the firm is intravenous Tramadol, a treatment for moderate to moderately severe postoperative pain.

Roth Capital analyst Scott Henry has a Buy rating on Avenue Therapeutics, Inc. (NASDAQ:ATXI) stock with a price target of $5. In a recent investor note, the analyst cited regulatory progress with regards to a key pipeline drug for the firm as a “positive”. 

At the end of the third quarter of 2021, 4 hedge funds in the database of Insider Monkey held stakes worth $360,000 in Avenue Therapeutics, Inc. (NASDAQ:ATXI), compared to 3 in the previous quarter worth $456,000.

4. SeaChange International, Inc. (NASDAQ:SEAC)

Number of Hedge Fund Holders: 4

Real-Time Share Price as of December 14: $1.72    

SeaChange International, Inc. (NASDAQ:SEAC) provides video products and services. In August, the company had announced that it had built a premium streaming service to broadcast a variety of Israeli channels and content outside the country.

SeaChange International, Inc. (NASDAQ:SEAC) stock has more than doubled in the past few days after reports emerged that the company was planning to merge with Triller, a direct social media rival of the popular TikTok platform. 

Among the hedge funds being tracked by Insider Monkey, New York-based firm Two Sigma Advisors is a leading shareholder in SeaChange International, Inc. (NASDAQ:SEAC) with 764,190 shares worth more than $810,000. 

3. Dynatronics Corporation (NASDAQ:DYNT)

Number of Hedge Fund Holders: 5 

Real-Time Share Price as of December 14: $1.09      

Dynatronics Corporation (NASDAQ:DYNT) operates as a medical device company. The firm exports products to over 30 countries around the globe. It was founded in 1979 and is headquartered in Minnesota. 

Dynatronics Corporation (NASDAQ:DYNT) sells products related to physical therapy, rehabilitation, orthopedics, pain management, and athletic training. The company has a market cap of $20 million. 

At the end of the third quarter of 2021, 5 hedge funds in the database of Insider Monkey held stakes worth $1.7 million in Dynatronics Corporation (NASDAQ:DYNT), up from 2 in the preceding quarter worth $898,000. 

2. Savara Inc. (NASDAQ:SVRA)

Number of Hedge Fund Holders: 9  

Real-Time Share Price as of December 14: $1.09    

Savara Inc. (NASDAQ:SVRA) is a biotech firm based in Texas. In June, the firm had revealed that the first patient had been dosed in a late-stage trial of the drug molgramostim in patients with autoimmune pulmonary alveolar proteinosis, a rare lung disease.

Savara Inc. (NASDAQ:SVRA) posted earnings for the third quarter in early November, beating analyst estimates on earnings per share by $0.02. The cash, cash equivalents, and short-term investments at the end of September stood at around $171 million. 

At the end of the third quarter of 2021, 9 hedge funds in the database of Insider Monkey held stakes worth $22 million in Savara Inc. (NASDAQ:SVRA), compared to 12 in the preceding quarter worth $28 million. 

1. Ardelyx, Inc. (NASDAQ:ARDX)

Number of Hedge Fund Holders: 10   

Real-Time Share Price as of December 14: $1.37      

Ardelyx, Inc. (NASDAQ:ARDX) is a biopharma firm that concentrates on the development of medicines for the treatment of kidney and cardiorenal diseases. The stock has surged by over 95% in the past week after the firm announced plans to launch Ibsrela, a treatment for irritable bowel syndrome with constipation, in the second quarter of 2022.

Citi analyst Yigal Nochomovitz recently raised the price target on Ardelyx, Inc. (NASDAQ:ARDX) stock to $13 from $7 and kept a Buy rating, noting the development of pipeline drugs of the firm and a decision to launch products independently from 2022. 

At the end of the third quarter of 2021, 10 hedge funds in the database of Insider Monkey held stakes worth $6.3 million in Ardelyx, Inc. (NASDAQ:ARDX), compared to 20 in the preceding quarter worth $241 million.

You can also take a peek at 10 Companies that Benefit From Crypto Mining and 10 Best Blue Chip Dividend Stocks Hedge Funds are Buying.